At least 27 venture capital firms have announced new life sciences funds in 2025, collectively raising over $12 billion. Among these, four firms reported funds exceeding $1 billion each. The announcements highlight significant investment activity within the life sciences sector this year.
The newly launched funds reflect a continued focus on advancing biotechnology and healthcare innovation. These investments are expected to support research and development initiatives across various areas of life sciences, including drug discovery, medical technology, and diagnostics. The substantial funding raised by multiple firms underscores the growing interest in fostering advancements in health-related fields.
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
For any suggestion and feedback, please contact us.
Date: December 16, 2025
